-
-
-
-
-
-
-
Theravance Biopharma (TBPH), Mylan (MYL) Announce New Data from Phase 3 Studies of YUPELRI (revefenacin) at ERS Congres 2018
-
-
-
-
-
-
-
Mylan (MYL) and Theravance Biopharma (TBHP) Report FDA Acceptance of New Drug Application for Revefenacin (TD-4208)
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

